REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $292,646,109 | +6.3% | 10,572,475 | +2.7% | 0.06% | +13.5% |
| Q2 2023 | $275,249,182 | +21.9% | 10,289,689 | -1.3% | 0.05% | +15.6% |
| Q1 2023 | $225,813,473 | +6.8% | 10,425,368 | +17.5% | 0.04% | +7.1% |
| Q4 2022 | $211,378,062 | +45.2% | 8,873,974 | +20.2% | 0.04% | +35.5% |
| Q3 2022 | $145,557,000 | +21.1% | 7,381,179 | +19.6% | 0.03% | +29.2% |
| Q2 2022 | $120,233,000 | +15.4% | 6,169,002 | +51.1% | 0.02% | +33.3% |
| Q1 2022 | $104,183,000 | -8.2% | 4,083,989 | -9.5% | 0.02% | 0.0% |
| Q4 2021 | $113,539,000 | -9.0% | 4,510,895 | -0.6% | 0.02% | -14.3% |
| Q3 2021 | $124,815,000 | -29.5% | 4,537,102 | -18.7% | 0.02% | -27.6% |
| Q2 2021 | $177,081,000 | -1.6% | 5,579,048 | +42.3% | 0.03% | -9.4% |
| Q1 2021 | $179,881,000 | +1856.9% | 3,920,648 | +1588.5% | 0.03% | +1500.0% |
| Q4 2020 | $9,192,000 | +29.6% | 232,191 | +13.9% | 0.00% | +100.0% |
| Q3 2020 | $7,093,000 | -20.5% | 203,839 | -27.9% | 0.00% | -50.0% |
| Q2 2020 | $8,925,000 | +21.0% | 282,741 | -16.0% | 0.00% | 0.0% |
| Q1 2020 | $7,376,000 | – | 336,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |